Skip to main content
. 2016 Sep 12;5(4):223–231. doi: 10.2217/cns-2016-0017

Figure 5. . Tumor growth and animal survival after 131I-CLR1404 therapy.

Figure 5. 

Nude mice harboring human tumor xenografts (n = 6 renal, 6 colorectal, 5 ovarian and 9 breast) were administered a single, nonoptimized 131I-CLR1404 dose (arrow). Control animals were administered a mass-equivalent CLR1404 dose (n = 6).

Reprinted with permission from [3] © AAAS.